+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Application of a ternary HP-β-CD-complex approach to improve the dissolution performance of a poorly soluble weak acid under biorelevant conditions



Application of a ternary HP-β-CD-complex approach to improve the dissolution performance of a poorly soluble weak acid under biorelevant conditions



International Journal of Pharmaceutics 430(1-2): 176-183



Over the last decades the poor solubility of new drugs has become an important issue, with one of the main challenges being to develop oral dosage forms with acceptable bioavailability for such compounds. The specific purpose of our study was to combine the advantages of cyclodextrins with those of solid dispersion approaches to improve the bioavailability of poorly soluble weak acids. Glyburide, an antidiabetic, was used as a model drug. First, binary drug inclusion complexes were prepared with 2-hydroxypropyl-β-cyclodextrin. Next, solid glyburide dispersions were prepared with polyvinylpyrrolidone (PVP) and a relatively new hydrophilic copolymer, Kollicoat IR. Finally, to check for potential synergistic effects of the two types of excipients, ternary inclusion complexes were formulated by keeping the 1:2 drug:CD ratio constant but varying the polymer concentration (5-20%). The formulations were analyzed by differential scanning calorimetry and subjected to solubility and dissolution experiments in compendial and biorelevant media. The results of the study clearly indicate that all formulations result in better in vitro performance of the drug. Best results were obtained with the ternary inclusion complexes containing 10% Kollicoat IR or 20% PVP K30. This formulation approach, particularly with the new polymer, appears to be promising in terms of enhancing the bioavailability of BCS class II drugs.

(PDF emailed within 0-6 h: $19.90)

Accession: 051607761

Download citation: RISBibTeXText

PMID: 22531855

DOI: 10.1016/j.ijpharm.2012.04.029



Related references

Predicting the oral absorption of a poorly soluble, poorly permeable weak base using biorelevant dissolution and transfer model tests coupled with a physiologically based pharmacokinetic model. European Journal of Pharmaceutics and Biopharmaceutics 82(1): 127-138, 2013

Biorelevant dissolution of poorly soluble weak acids studied by UV imaging reveals ranges of fractal-like kinetics. International Journal of Pharmaceutics 463(1): 38-49, 2014

Forecasting the oral absorption behavior of poorly soluble weak bases using solubility and dissolution studies in biorelevant media. Pharmaceutical Research (New York) 19(3): 345-349, 2002

Characterising the behaviour of poorly water soluble drugs in the intestine: application of biorelevant media for solubility, dissolution and transport studies. Journal of Pharmacy and Pharmacology 62(11): 1656-1668, 2011

Dissolution rate and apparent solubility of poorly soluble drugs in biorelevant dissolution media. Molecular Pharmaceutics 7(5): 1419-1430, 2013

In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media. European Journal of Pharmaceutical Sciences 24(4): 305-313, 2005

Crystal suspensions of poorly soluble peptides for intra-articular application: a novel approach for biorelevant assessment of their in vitro release. International Journal of Pharmaceutics 461(1-2): 46-53, 2015

Modifying the diffusion layer of soluble salts of poorly soluble basic drugs to improve dissolution performance. Molecular Pharmaceutics 7(5): 1441-1449, 2013

Using biorelevant dissolution to obtain IVIVC of solid dosage forms containing a poorly-soluble model compound. European Journal of Pharmaceutics and Biopharmaceutics 69(2): 648-657, 2008

Application of carrier and plasticizer to improve the dissolution and bioavailability of poorly water-soluble baicalein by hot melt extrusion. Aaps Pharmscitech 15(3): 560-568, 2015

Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: itraconazole. European Journal of Pharmaceutics and Biopharmaceutics 83(3): 378-387, 2013

Impact of sodium dodecyl sulphate on the dissolution of poorly soluble drug into biorelevant medium from drug-surfactant discs. International Journal of Pharmaceutics 467(1-2): 1-8, 2014

Biorelevant solubility of poorly soluble drugs: rivaroxaban, furosemide, papaverine and niflumic acid. Journal of Pharmaceutical and Biomedical Analysis 83: 279-285, 2014

Effect of binary and ternary solid dispersions prepared by fusion method on the dissolution of poorly water soluble diacerein. 2013

The impact of reduced gastric acid secretion on dissolution of salts of weak bases in the fasted upper gastrointestinal lumen: Data in biorelevant media and in human aspirates. European Journal of Pharmaceutics and Biopharmaceutics 115: 94-101, 2017